Inter Press Service: Many Kenyan Children Miss Out on Life-Saving Drugs
"Thanks to antiretroviral drugs, HIV-positive children can now live to adulthood. Yet a significant number of children living with HIV in Kenya will die due to delay in receiving antiretroviral drugs (ARVs), inconsistent use of ARVs or, simply, no ARVs. ... [A] UNICEF report lists several barriers to pediatric ART [antiretroviral therapy]. Among them are limited availability of fixed-dose ARV combinations, poor palatability of recommended drug formulations for infants, lack of technology to test HIV infection among children under 18 months and fewer ART options for children than for adults ..." (Gathigah, 1/10).
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.